News Releases
Thursday, April 18, 2019
Estimating the Efficacy and Cost of Curative Gene Therapy for Beta-ThalassemiaThursday, March 28, 2019
New Study Confirms EpCAM as Promising Target for Cancer ImmunotherapyWednesday, November 14, 2018
Urocortin 3 Gene Therapy Increases Systolic and Diastolic Function in Heart FailureTuesday, November 13, 2018
Combination Gene Therapy More Effective in Cartilage Preservation In Moderate and Severe OsteoarthritisFriday, October 19, 2018
Advantages of DNA Immunization Platform for Eliciting Monoclonal Antibodies in Multiple SpeciesThursday, October 18, 2018
Novel DNA Vaccine Design Based on Micro-Consensus Sequences Offers Broad Protection Against Influenza-A H3N2Wednesday, September 19, 2018
Is the End of the Recombinant DNA Advisory Committee (RAC) a Good Thing?Monday, August 20, 2018
Promising Results Support Continued Development of AAV-Based Human Factor VIII Gene TherapyWednesday, August 15, 2018
Longest Reported Efficacy and Safety of AAV5-Based Gene Therapy to Treat Day Blind Sheep with AchromatopsiaMonday, August 13, 2018
Single Injection of Novel Gene Therapy Vector Prolonged Survival in Mouse Model of Pompe Disease
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.
